17:04 EDT Caribou Biosciences (CRBU) files $300M mixed securities shelf
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBU:
- Caribou Biosciences price target lowered to $9 from $11 at BofA
- Strategic Refocus and Upcoming Catalysts Support Buy Rating for Caribou Biosciences
- Caribou Biosciences price target lowered to $3 from $9 at H.C. Wainwright
- Strategic Restructuring and Focus on Oncology Drive Buy Rating for Caribou Biosciences
- Caribou reduces workforce by 32%, discontinues GALLOP and AMpLify trials